Energy optimization typically plateaus at elevated but stable levels that reflect the individual's new antioxidant baseline
Focus on eating whole grains, fruits, vegetables, lean proteins, and healthy fats
The Results: Tirzepatide Wins By a Significant Margin At 72 weeks, the results were unambiguous: Tirzepatide: average body weight loss of 20.2% Semaglutide: average body weight loss of 13.7% That gap 6.5 percentage points is not a small difference
Under the primary analysis method, the treatment models for generating propensity scores were generalized boosted models [16] with the treatment indicator as a binary outcome and baseline covariates including sociodemographic variables: age (continuous), sex, race, ethnicity, geographic region, education level, individual and household income